A detailed history of Commonwealth Equity Services, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 15,554 shares of SLS stock, worth $17,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,554
Previous 15,554 -0.0%
Holding current value
$17,109
Previous $19,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$1.06 - $1.63 $1,590 - $2,445
1,500 Added 10.67%
15,554 $19,000
Q1 2024

Apr 29, 2024

BUY
$0.51 - $1.55 $836 - $2,542
1,640 Added 13.21%
14,054 $14,000
Q2 2023

Aug 10, 2023

BUY
$1.35 - $1.8 $16,758 - $22,345
12,414 New
12,414 $19,000

Others Institutions Holding SLS

About SELLAS Life Sciences Group, Inc.


  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $22.6M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.